Afleveringen
-
Can AI/machine learning-driven digital phenotyping facilitate global personalized medicine? In this Q&A, Vikram Patel, MBBS, PhD, the Paul Farmer Professor and chair of the Department of Global Health and Social Medicine at Harvard Medical School, joins JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss how AI can enhance assessment and treatment solutions across lower-income nations.
One Day, AI Could Mean Better Mental Health for All
Related Content: -
An Explosion of Food Is Medicine Research Could Change Health Care; Blockbuster Obesity Drugs Have Potential New Uses
Could GLP-1 Receptor Agonists Like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions? Produce Prescriptions Sound Good, but Data to Support Them Are LackingâThat Could Soon Change
Related Content: -
Zijn er afleveringen die ontbreken?
-
Douglas Drachman, MD, shares late-breaking research from the annual conference of the American College of Cardiology and World Congress of Cardiology in an interview with JAMA Medical News Director Jennifer Abbasi. Dr Drachmanâwho chaired this yearâs conferenceâis an interventional cardiologist at Massachusetts General Hospital, where he is also director of education in the cardiology division.
Clinical Highlights From the American College of Cardiologyâs 2024 Scientific Session
Related Content: -
Momentum Grows for Disaggregated Asian American Health Data; What Clinicians Need to Know About TikTok
Researchers Are Working to Disaggregate Asian American Health DataâHereâs Why Itâs Long Overdue Patients Are Turning to TikTok for Health InformationâHereâs What Clinicians Need to Know
Related Content: -
Could generative AI assist in extending access to vulnerable populations and begin to bridge the gap in disparities? In this Q&A, Davey Smith, MD, MAS, an infectious disease specialist and virologist at the University of California, San Diego, joins JAMA's Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to explore the implications of large language models for improving patient outcomes.
Will Generative AI Tools Improve Access to Reliable Health Information?
Related Content: -
Measles Is Spreading Again in the US; Questions Surround Blood Tests That Claim to Screen for Multiple Cancers; Study Provides Insight Into Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Measles Cases Are Spreading in the USâHereâs What to Know Questions Swirl Around Screening for Multiple Cancers With a Single Blood Test NIH Study Provides Long-Awaited Insight Into Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Related Content: -
AI can understand brain signals linked to the sensory and motor processes involved in speech. In this Q&A, Edward Chang, MD, the chair and professor of neurosurgery at UCSF joins JAMA's Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss how AI has the potential to facilitate communication and how close AI development is to being able to translate human emotion.
Digital Avatars and Personalized VoicesâHow AI Is Helping to Restore Speech to Patients
Related Content: -
Can AI enhance the speed and efficiency of interpreting ultrasounds and echocardiograms, thereby minimizing diagnostic errors? In this Q&A, Rima Arnaout, MD, a cardiologist and associate professor of medicine at the University of California-San Francisco, joins JAMA's Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss the transformative impact of AI on cardiac imaging.
How Machine Learning Might Help Improve Cardiac Imaging
Related Content: -
Rural Maternity Care Is in CrisisâHereâs What Could Help; Type and Severity of Immunodeficiency Affect Speed of SARS-CoV-2 Clearance, Study Finds
More Than Half of US Rural Hospitals No Longer Offer Birthing ServicesâHereâs Why When It Comes to SARS-CoV-2 Clearance, People Who Are Immunocompromised Are Not All Alike
Related Content: -
Automation bias and shortcuts in clinical AI models have posed significant challenges. In this Q&A, Jenna Wiens, PhD, an associate professor of Computer Science and Engineering at the University of Michigan in Ann Arbor, joins JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss how we can start leveraging human collaboration with AI to provide more effective health care.
Blind Spots, Shortcuts, and Automation BiasâResearchers Are Aiming to Improve AI Clinical Models
Related Content: -
AI in clinical practice needs ethical frameworks to avert future biases. In this Q&A, Marzyeh Ghassemi, PhD, the Herman L. F. von Helmholtz Career Development Professor at MIT in Electrical Engineering and Computer Science (EECS), joins JAMA's Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss ethical machine learning and responsible clinical implementation.
AI Developers Should Understand the Risks of Deploying Their Clinical Tools, MIT Expert Says
Related Content: -
What the Latest Research Says About Paxlovid; People Are Using Potentially Dangerous âTrip-Killersâ to Counter Psychedelics; Social Media Affects Youth Mental HealthâHereâs What Could Help
Paxlovid Is Effective but UnderusedâHereâs What the Latest Research Says About Rebound and More Study Finds Hundreds of Reddit Posts on âTrip-Killersâ for Psychedelic Drugs Social Media Industry Standards Needed to Protect Adolescent Mental Health, Says National Academies
Related Content: -
After a Decade, Goodbye to the Pooled Cohort Equations? Experts Tackle Racial Bias in Clinical Algorithms; How COVID-19 Might Be Tied to Other Respiratory Disease Outbreaks
What to Know About PREVENT, the AHAâs New Cardiovascular Disease Risk Calculator Citing Harms, Momentum Grows to Remove Race From Clinical Algorithms From âImmunity Debtâ to âImmunity TheftââHow COVID-19 Might Be Tied to Recent Respiratory Disease Surges
Related Content: -
How can we leverage AI to transform health care into a more efficient model for delivering care? In this Q&A, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, interviews Atul Butte, MD, PhD, the director of the Bakar Computational Health Sciences Institute at UCSF, to discuss scalable privilege and the need for the broad distribution of AI-driven expertise.
âScalable PrivilegeââHow AI Could Turn Data From the Best Medical Systems Into Better Care for All
Related Content: -
Amid the surging buzz around artificial intelligence (AI), can we trust the Al hype, and more importantly, are we ready for its implications? In this Q&A, Arvind Narayanan, PhD, a professor of computer science at Princeton, joins JAMA's Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss the exploration of Al's fairness, transparency, and accountability.
How to Navigate the Pitfalls of AI Hype in Health Care
Related Content: -
The Next Generation of COVID-19 Vaccines May Be Inhaled; Does Paxlovid Prevent Long COVID? Apply to the Morris Fishbein Fellowship in Medical Editing.
Up the Nose and Down the Windpipe May Be the Path to New and Improved COVID-19 Vaccines Studies Investigate Whether Antivirals Like Paxlovid May Prevent Long COVID
Related Content:The Morris Fishbein Fellowship in Medical Editing
-
Artificial intelligence holds the promise of revolutionizing disease diagnosis and prediction, but it also presents a pivotal challenge: ensuring equity. In this Q&A, Alondra Nelson, PhD, the Harold F. Linder Professor at the Institute for Advanced Study, joins JAMA's Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss the equitable regulation of AI to benefit all populations.
How Do Policymakers Regulate AI and Accommodate Innovation in Research and Medicine?
Related Content: -
In this Q&A, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, interviews John Ayers, PhD, MA, vice chief of innovation in the Division of Infectious Diseases & Global Public Health, deputy director of informatics in the Altman Clinical and Translational Research Institute, and affiliate scientist in the Qualcomm Institute, all at UC San Diego, to discuss how genAI programs like ChatGPT can increase communication pathways and improve patient outcomes.
How AI Assistants Could Help Answer Patientsâ Messagesâand Potentially Improve Their Outcomes
Related Content: -
Why Physicians Donât Deprescribe Medicines; What to Know About Wegovyâs Rare but Serious Adverse Effects; What to Know About Zepbound, the Newest Antiobesity Drug
As Semaglutideâs Popularity Soars, Rare but Serious Adverse Effects Are Emerging FDA Green-Lights Tirzepatide, Marketed as Zepbound, for Chronic Weight Management Deciding When Itâs Better to Deprescribe Medicines Than to Continue Them
Related Content: -
JAMA Associate Editor Gregory Marcus, MD, a cardiologist and professor of medicine at the University of California San Francisco, speaks with American Heart Association Scientific Sessions 2023 conference chair Amit Khera, MD, MSc, a professor in the department of internal medicine at UT Southwestern Medical Center and the director of preventive cardiology.
Highlights From AHA 2023âNew Risk Calculator, Semaglutide and CVD, and More
Related Content: - Laat meer zien